FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074026983> ?p ?o ?g. }

• W2074026983 endingPage "92" @default.
• W2074026983 startingPage "85" @default.
• W2074026983 abstract "A study was undertaken to evaluate and compare faecal excretion of moxidectin and ivermectin in horses after oral administration of commercially available preparations. Ten clinically healthy adult horses, weighing 390–446 kg body weight (b.w.), were allocated to two experimental groups. Group I was treated with an oral gel formulation of moxidectin at the manufacturer’s recommended therapeutic dose of 0.4 mg/kg b.w. Group II was treated with an oral paste formulation of ivermectin at the recommended dose of 0.2 mg/kg b.w. Faecal samples were collected at different times between 1 and 75 days post-treatment. After faecal drug extraction and derivatization, samples were analysed by High Performance Liquid Chromatography using fluorescence detection and computerized kinetic analysis. For both drugs the maximum concentration level was reached at 2.5 days post administration. The ivermectin treatment groups’ faecal concentrations remained above the detectable level for 40 days (0.6 ± 0.3 ng/g), whereas the moxidectin treatment group remained above the detectable level for 75 days (4.3 ± 2.8 ng/g). Ivermectin presented a faster elimination rate than moxidectin, reaching 90% of the total drug excreted in faeces at four days post-treatment, whereas moxidectin reached similar levels at eight days post-treatment. No significant differences were observed for the values of maximum faecal concentration (Cmax) and time of Cmax(Tmax) between both groups of horses, demonstrating similar patterns of drug transference from plasma to the gastrointestinal tract. The values of the area under the faecal concentration time curve were slightly higher in the moxidectin treatment group (7104 ± 2277 ng.day/g) but were not significantly different from those obtained in the ivermectin treatment group (5642 ± 1122 ng.day/g). The results demonstrate that although a 100% higher dose level of moxidectin was used, attaining higher plasma concentration levels and more prolonged excretion and gut secretion than ivermectin, the concentration in faeces only represented 44.3± 18.0% of the total parental drug administered compared to 74.3 ± 20.2% for ivermectin. This suggests a higher level of metabolization for moxidectin in the horse." @default.
• W2074026983 created "2016-06-24" @default.
• W2074026983 creator A5002911512 @default.
• W2074026983 creator A5029630843 @default.
• W2074026983 creator A5035417382 @default.
• W2074026983 creator A5049544903 @default.
• W2074026983 creator A5065234493 @default.
• W2074026983 date "2001-01-01" @default.
• W2074026983 modified "2023-10-12" @default.
• W2074026983 title "Faecal Excretion Profile of Moxidectin and Ivermectin after Oral Administration in Horses" @default.
• W2074026983 cites W1967592611 @default.
• W2074026983 cites W1969453948 @default.
• W2074026983 cites W1971878874 @default.
• W2074026983 cites W1973003433 @default.
• W2074026983 cites W1974747859 @default.
• W2074026983 cites W1978521805 @default.
• W2074026983 cites W1982133489 @default.
• W2074026983 cites W1984447784 @default.
• W2074026983 cites W1997058022 @default.
• W2074026983 cites W2003206811 @default.
• W2074026983 cites W2004140882 @default.
• W2074026983 cites W2013289108 @default.
• W2074026983 cites W2017659007 @default.
• W2074026983 cites W2021690233 @default.
• W2074026983 cites W2022243311 @default.
• W2074026983 cites W2024817154 @default.
• W2074026983 cites W2040858278 @default.
• W2074026983 cites W2043694686 @default.
• W2074026983 cites W2047099969 @default.
• W2074026983 cites W2052535602 @default.
• W2074026983 cites W2059172348 @default.
• W2074026983 cites W2075975707 @default.
• W2074026983 cites W2083821257 @default.
• W2074026983 cites W2110712892 @default.
• W2074026983 cites W2117394170 @default.
• W2074026983 cites W2129944877 @default.
• W2074026983 cites W2148386710 @default.
• W2074026983 doi "https://doi.org/10.1053/tvjl.2000.0521" @default.
• W2074026983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11145833" @default.
• W2074026983 hasPublicationYear "2001" @default.
• W2074026983 type Work @default.
• W2074026983 sameAs 2074026983 @default.
• W2074026983 citedByCount "36" @default.
• W2074026983 countsByYear W20740269832012 @default.
• W2074026983 countsByYear W20740269832013 @default.
• W2074026983 countsByYear W20740269832014 @default.
• W2074026983 countsByYear W20740269832016 @default.
• W2074026983 countsByYear W20740269832018 @default.
• W2074026983 countsByYear W20740269832019 @default.
• W2074026983 countsByYear W20740269832020 @default.
• W2074026983 countsByYear W20740269832021 @default.
• W2074026983 countsByYear W20740269832022 @default.
• W2074026983 countsByYear W20740269832023 @default.
• W2074026983 crossrefType "journal-article" @default.
• W2074026983 hasAuthorship W2074026983A5002911512 @default.
• W2074026983 hasAuthorship W2074026983A5029630843 @default.
• W2074026983 hasAuthorship W2074026983A5035417382 @default.
• W2074026983 hasAuthorship W2074026983A5049544903 @default.
• W2074026983 hasAuthorship W2074026983A5065234493 @default.
• W2074026983 hasConcept C10146269 @default.
• W2074026983 hasConcept C112705442 @default.
• W2074026983 hasConcept C126322002 @default.
• W2074026983 hasConcept C140793950 @default.
• W2074026983 hasConcept C22979827 @default.
• W2074026983 hasConcept C2776186584 @default.
• W2074026983 hasConcept C2777056448 @default.
• W2074026983 hasConcept C2777499811 @default.
• W2074026983 hasConcept C2780026642 @default.
• W2074026983 hasConcept C42972112 @default.
• W2074026983 hasConcept C61716771 @default.
• W2074026983 hasConcept C71924100 @default.
• W2074026983 hasConcept C86803240 @default.
• W2074026983 hasConcept C89423630 @default.
• W2074026983 hasConcept C90924648 @default.
• W2074026983 hasConcept C98274493 @default.
• W2074026983 hasConceptScore W2074026983C10146269 @default.
• W2074026983 hasConceptScore W2074026983C112705442 @default.
• W2074026983 hasConceptScore W2074026983C126322002 @default.
• W2074026983 hasConceptScore W2074026983C140793950 @default.
• W2074026983 hasConceptScore W2074026983C22979827 @default.
• W2074026983 hasConceptScore W2074026983C2776186584 @default.
• W2074026983 hasConceptScore W2074026983C2777056448 @default.
• W2074026983 hasConceptScore W2074026983C2777499811 @default.
• W2074026983 hasConceptScore W2074026983C2780026642 @default.
• W2074026983 hasConceptScore W2074026983C42972112 @default.
• W2074026983 hasConceptScore W2074026983C61716771 @default.
• W2074026983 hasConceptScore W2074026983C71924100 @default.
• W2074026983 hasConceptScore W2074026983C86803240 @default.
• W2074026983 hasConceptScore W2074026983C89423630 @default.
• W2074026983 hasConceptScore W2074026983C90924648 @default.
• W2074026983 hasConceptScore W2074026983C98274493 @default.
• W2074026983 hasIssue "1" @default.
• W2074026983 hasLocation W20740269831 @default.
• W2074026983 hasLocation W20740269832 @default.
• W2074026983 hasLocation W20740269833 @default.
• W2074026983 hasOpenAccess W2074026983 @default.
• W2074026983 hasPrimaryLocation W20740269831 @default.
• W2074026983 hasRelatedWork W1585566931 @default.

• next